marketcaparena
Search

    TFX

    TELEFLEX INC

    Company overview

    Market capitalization
    $5.40B
    Employees
    15,500
    Latest publication
    2026-09-29
    About TELEFLEX INC

    Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USD
    Total Revenue570,332,000USD780,889,000USD700,669,000USD764,375,000USD749,691,000USD737,849,000USD773,909,000USD746,389,000USD
    Cost Of Revenue238,625,000USD349,804,000USD311,230,000USD334,203,000USD333,233,000USD321,715,000USD342,492,000USD330,078,000USD
    Gross Profit331,707,000USD431,085,000USD389,439,000USD430,172,000USD416,458,000USD416,134,000USD431,417,000USD416,311,000USD
    Research Development45,122,000USD38,521,000USD36,404,000USD38,726,000USD41,094,000USD37,299,000USD35,858,000USD37,576,000USD
    Selling General Administrative213,515,000USD215,081,000USD222,710,000USD247,257,000USD250,631,000USD380,969,000USD260,651,000USD213,194,000USD
    Total Operating Expenses258,883,000USD275,774,000USD263,869,000USD280,861,000USD299,580,000USD420,927,000USD348,949,000USD251,001,000USD
    Operating Income72,824,000USD155,311,000USD125,570,000USD149,311,000USD116,878,000USD-4,793,000USD82,468,000USD165,310,000USD
    Total Other Income Expense Net-27,687,000USD-20,065,000USD-16,627,000USD-18,760,000USD-19,381,000USD-21,017,000USD-22,496,000USD-15,705,000USD
    Interest Income1,416,000USD1,643,000USD1,917,000USD2,298,000USD1,787,000USD1,666,000USD3,295,000USD7,487,000USD
    Interest Expense27,953,000USD21,708,000USD18,544,000USD21,058,000USD21,168,000USD22,683,000USD25,791,000USD23,192,000USD
    Income Before Tax45,137,000USD135,246,000USD108,943,000USD130,551,000USD97,497,000USD-25,810,000USD59,972,000USD149,605,000USD
    Income Tax Expense3,375,000USD12,662,000USD13,839,000USD19,633,000USD17,332,000USD-41,551,000USD28,789,000USD11,935,000USD
    Discontinued Operations57,931,000USD——————-530,000USD
    Net Income99,693,000USD122,580,000USD95,002,000USD111,004,000USD80,038,000USD15,289,000USD31,105,000USD137,140,000USD
    Unclassified Operating Expenses—22,172,000USD4,755,000USD-5,122,000USD7,855,000USD—52,440,000USD—
    Net Interest Income—-20,065,000USD-16,627,000USD-18,760,000USD-19,381,000USD-21,017,000USD-22,496,000USD-15,705,000USD
    Tax Provision—12,662,000USD13,839,000USD19,633,000USD17,332,000USD-41,551,000USD28,789,000USD11,935,000USD
    Net Income From Continuing Ops—122,584,000USD95,104,000USD110,918,000USD80,165,000USD15,741,000USD31,183,000USD137,670,000USD
    Ebit—156,954,000USD127,487,000USD151,609,000USD118,665,000USD-3,127,000USD85,763,000USD172,797,000USD
    Ebitda—222,666,000USD194,818,000USD220,245,000USD186,794,000USD62,917,000USD149,964,000USD230,391,000USD
    Depreciation And Amortization—65,712,000USD67,331,000USD68,636,000USD68,129,000USD66,044,000USD64,201,000USD57,594,000USD
    Reconciled Depreciation—65,712,000USD67,331,000USD68,636,000USD68,129,000USD66,044,000USD64,201,000USD57,594,000USD
    Net Income Applicable To Common Shares—122,580,000USD95,002,000USD111,004,000USD———137,140,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue3,047,324,000USD2,974,489,000USD2,791,041,000USD2,809,563,000USD2,537,156,000USD2,595,362,000USD2,448,383,000USD2,146,303,000USD
    Cost Of Revenue1,344,645,000USD1,327,558,000USD1,259,954,000USD1,259,961,000USD1,212,282,000USD1,186,357,000USD1,063,941,000USD974,501,000USD
    Gross Profit1,702,679,000USD1,646,931,000USD1,531,087,000USD1,549,602,000USD1,324,874,000USD1,409,005,000USD1,384,442,000USD1,171,802,000USD
    Research Development161,672,000USD154,351,000USD153,819,000USD130,841,000USD119,747,000USD113,857,000USD106,208,000USD84,770,000USD
    Selling General Administrative995,271,000USD902,591,000USD863,748,000USD860,085,000USD743,568,000USD934,373,000USD878,688,000USD699,963,000USD
    Unclassified Operating Expenses394,723,000USD83,676,000USD13,795,000USD-69,419,000USD38,491,000USD-66,479,000USD——
    Total Operating Expenses1,551,666,000USD1,140,618,000USD1,031,362,000USD921,507,000USD901,806,000USD981,751,000USD984,896,000USD784,733,000USD
    Operating Income151,013,000USD506,313,000USD499,725,000USD628,095,000USD423,068,000USD427,254,000USD321,704,000USD372,279,000USD
    Interest Income8,009,000USD9,821,000USD53,352,000USD55,641,000USD1,158,000USD1,741,000USD944,000USD771,000USD
    Interest Expense83,544,000USD85,082,000USD54,264,000USD56,969,000USD66,494,000USD80,270,000USD103,020,000USD82,546,000USD
    Net Interest Income-75,535,000USD-68,522,000USD-53,352,000USD-55,641,000USD-65,336,000USD-78,529,000USD-102,076,000USD-81,775,000USD
    Income Before Tax75,478,000USD434,012,000USD445,919,000USD559,468,000USD357,732,000USD339,903,000USD219,628,000USD284,911,000USD
    Income Tax Expense5,316,000USD76,440,000USD83,003,000USD74,349,000USD21,931,000USD-122,078,000USD23,196,000USD129,648,000USD
    Tax Provision5,316,000USD76,440,000USD83,003,000USD74,349,000USD21,931,000USD-122,078,000USD23,196,000USD129,648,000USD
    Net Income69,675,000USD356,328,000USD363,139,000USD485,374,000USD335,324,000USD461,466,000USD200,802,000USD152,530,000USD
    Net Income From Continuing Ops70,162,000USD357,572,000USD362,916,000USD485,119,000USD335,801,000USD461,981,000USD196,432,000USD155,263,000USD
    Ebit159,022,000USD519,094,000USD500,183,000USD616,437,000USD424,226,000USD420,173,000USD322,648,000USD367,457,000USD
    Ebitda433,623,000USD761,212,000USD730,773,000USD853,799,000USD651,478,000USD634,235,000USD532,628,000USD522,720,000USD
    Depreciation And Amortization274,601,000USD242,118,000USD230,590,000USD237,362,000USD227,252,000USD214,062,000USD209,980,000USD155,263,000USD
    Reconciled Depreciation274,601,000USD237,527,000USD230,590,000USD237,362,000USD227,252,000USD214,062,000USD209,980,000USD155,263,000USD
    Total Other Income Expense Net-75,535,000USD-72,301,000USD-53,806,000USD-68,627,000USD-65,336,000USD-87,351,000USD23,196,000USD-87,368,000USD
    Net Income Applicable To Common Shares69,675,000USD356,328,000USD363,139,000USD485,374,000USD335,324,000USD461,466,000USD200,802,000USD152,530,000USD
    Non Operating Income Net Other——458,000USD-11,658,000USD1,158,000USD-7,081,000USD944,000USD-4,822,000USD
    Discontinued Operations——223,000USD255,000USD-477,000USD-515,000USD4,370,000USD-2,733,000USD
    Minority Interest——————0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets6,786,778,000USD6,783,002,000USD6,947,239,000USD7,871,940,000USD7,375,219,000USD7,163,290,000USD7,097,914,000USD7,486,291,000USD
    Cash And Equivalents300,159,000USD—378,564,000USD353,997,000USD253,697,000USD284,122,000USD290,188,000USD243,235,000USD
    Total Current Assets1,875,876,000USD1,859,670,000USD1,938,338,000USD1,985,984,000USD1,723,862,000USD1,538,914,000USD1,471,124,000USD1,499,303,000USD
    Other Current Assets148,222,000USD803,872,000USD795,096,000USD236,870,000USD262,667,000USD146,297,000USD121,308,000USD145,873,000USD
    Other Non Current Assets120,310,000USD———————
    Total Liabilities3,882,244,000USD———————
    Total Current Liabilities720,379,000USD728,049,000USD762,026,000USD773,033,000USD716,148,000USD675,909,000USD649,360,000USD618,753,000USD
    Other Current Liabilities88,364,000USD———————
    Other Non Current Liabilities51,974,000USD———————
    Total Stockholder Equity2,904,534,000USD3,084,436,000USD3,124,768,000USD3,821,863,000USD4,242,868,000USD4,095,164,000USD4,278,140,000USD4,481,717,000USD
    Total Equity Including Noncontrolling Interest2,904,534,000USD———————
    Short Long Term Debt87,500,000USD103,125,000USD100,000,000USD100,000,000USD100,000,000USD100,000,000USD100,000,000USD96,875,000USD
    Long Term Debt2,720,509,000USD2,514,268,000USD2,541,449,000USD2,571,504,000USD1,801,645,000USD1,807,321,000USD1,555,871,000USD1,661,546,000USD
    Net Receivables364,609,000USD365,526,000USD345,583,000USD592,652,000USD513,812,000USD464,523,000USD459,495,000USD470,257,000USD
    Inventory351,912,000USD380,861,000USD404,395,000USD802,465,000USD693,686,000USD643,972,000USD600,133,000USD639,938,000USD
    Property Plant Equipment Net552,795,000USD561,867,000USD590,098,000USD807,638,000USD648,058,000USD627,256,000USD611,764,000USD625,119,000USD
    Goodwill2,292,435,000USD———————
    Intangible Assets1,448,669,000USD1,485,885,000USD1,524,150,000USD2,410,406,000USD2,184,312,000USD2,226,144,000USD2,268,714,000USD2,325,105,000USD
    Accounts Payable143,292,000USD143,627,000USD130,201,000USD165,908,000USD157,558,000USD143,037,000USD141,031,000USD119,255,000USD
    Short Term Debt87,500,000USD103,125,000USD100,000,000USD100,000,000USD100,000,000USD100,000,000USD100,000,000USD96,875,000USD
    Total Liab—3,698,566,000USD3,822,471,000USD4,050,077,000USD3,132,351,000USD3,068,126,000USD2,819,774,000USD3,004,574,000USD
    Other Current Liab—469,473,000USD513,038,000USD507,125,000USD436,096,000USD383,092,000USD367,011,000USD383,942,000USD
    Common Stock—48,197,000USD48,197,000USD48,197,000USD48,197,000USD48,191,000USD48,096,000USD48,096,000USD
    Capital Stock—48,197,000USD48,197,000USD48,197,000USD48,197,000USD48,191,000USD48,096,000USD48,096,000USD
    Retained Earnings—3,126,509,000USD3,149,760,000USD3,879,165,000USD4,303,130,000USD4,195,628,000USD4,115,870,000USD4,268,259,000USD
    Good Will—2,297,447,000USD2,305,050,000USD2,537,777,000USD2,694,052,000USD2,651,886,000USD2,632,314,000USD2,918,562,000USD
    Cash—309,411,000USD393,264,000USD353,997,000USD253,697,000USD284,122,000USD290,188,000USD243,235,000USD
    Cash And Short Term Investments—309,411,000USD393,264,000USD353,997,000USD253,697,000USD284,122,000USD290,188,000USD243,235,000USD
    Net Debt—2,376,302,000USD2,332,395,000USD2,415,157,000USD1,741,454,000USD1,720,860,000USD1,464,837,000USD1,618,124,000USD
    Short Long Term Debt Total—2,685,713,000USD2,725,659,000USD2,769,154,000USD1,995,151,000USD2,004,982,000USD1,755,025,000USD1,861,359,000USD
    Property Plant Equipment Gross—561,867,000USD1,060,153,000USD807,638,000USD648,058,000USD627,256,000USD1,222,446,000USD625,119,000USD
    Accumulated Other Comprehensive Income—-258,943,000USD-239,468,000USD-263,678,000USD-258,654,000USD-293,079,000USD-316,669,000USD-258,240,000USD
    Common Stock Shares Outstanding—44,257,000shares44,238,000shares44,237,000shares45,926,000shares45,926,000shares46,373,000shares47,012,000shares
    Non Current Assets Total—4,923,332,000USD5,008,901,000USD5,885,956,000USD5,651,357,000USD5,624,376,000USD5,626,790,000USD5,986,988,000USD
    Non Current Liabilities Total—2,970,517,000USD3,060,445,000USD3,277,044,000USD2,416,203,000USD2,392,217,000USD2,170,414,000USD2,385,821,000USD
    Non Current Liabilities Other—166,338,000USD198,068,000USD151,430,000USD125,612,000USD81,261,000USD104,138,000USD151,948,000USD
    Non Currrent Assets Other—565,927,000USD565,817,000USD103,067,000USD96,544,000USD107,317,000USD102,624,000USD111,423,000USD
    Net Working Capital—1,131,621,000USD1,176,312,000USD1,212,951,000USD1,007,714,000USD863,005,000USD821,764,000USD880,550,000USD
    Unclassified Current Liabilities—-91,301,000USD-81,213,000USD-100,000,000USD-77,506,000USD-50,220,000USD-58,682,000USD-96,875,000USD
    Unclassified Non Current Liabilities—289,911,000USD320,928,000USD554,110,000USD488,946,000USD503,635,000USD510,405,000USD572,327,000USD
    Unclassified Equity—120,476,000USD118,082,000USD109,982,000USD101,998,000USD96,233,000USD382,747,000USD375,506,000USD
    Other Assets——589,603,000USD130,135,000USD124,935,000USD119,090,000USD113,998,000USD118,202,000USD
    Unclassified Non Current Assets——-565,817,000USD-103,067,000USD-96,544,000USD-107,317,000USD-102,624,000USD-111,423,000USD
    Short Term Investments——————15,972,000USD—
    Unclassified Current Assets——————-15,972,000USD—
    Current Deferred Revenue———————18,681,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets6,947,239,000USD7,097,914,000USD7,532,546,000USD6,928,063,000USD6,871,722,000USD7,152,559,000USD6,309,820,000USD6,277,991,000USD
    Intangible Assets1,524,150,000USD2,268,714,000USD2,501,960,000USD2,306,165,000USD2,289,067,000USD2,519,746,000USD2,156,285,000USD2,325,052,000USD
    Other Current Assets795,096,000USD105,336,000USD114,875,000USD131,608,000USD122,822,000USD138,278,000USD110,019,000USD84,944,000USD
    Total Liab3,822,471,000USD2,819,774,000USD3,091,558,000USD2,906,095,000USD3,116,974,000USD3,816,102,000USD3,330,500,000USD3,738,013,000USD
    Total Stockholder Equity3,124,768,000USD4,278,140,000USD4,440,988,000USD4,021,968,000USD3,754,748,000USD3,336,457,000USD2,979,320,000USD2,539,978,000USD
    Other Current Liab513,038,000USD367,011,000USD345,545,000USD342,449,000USD367,940,000USD319,646,000USD403,447,000USD383,179,000USD
    Common Stock48,197,000USD48,096,000USD48,046,000USD47,957,000USD47,929,000USD47,812,000USD47,536,000USD47,248,000USD
    Capital Stock48,197,000USD48,096,000USD48,046,000USD47,957,000USD47,929,000USD47,812,000USD47,536,000USD47,248,000USD
    Retained Earnings3,149,760,000USD4,115,870,000USD4,109,736,000USD3,817,304,000USD3,517,954,000USD3,096,228,000USD2,824,916,000USD2,427,599,000USD
    Good Will2,305,050,000USD2,632,314,000USD2,914,055,000USD2,536,730,000USD2,504,202,000USD2,585,966,000USD2,245,305,000USD2,246,579,000USD
    Other Assets589,603,000USD113,998,000USD105,691,000USD95,769,000USD75,924,000USD150,510,000USD44,953,000USD37,425,000USD
    Cash393,264,000USD290,188,000USD222,848,000USD292,034,000USD445,084,000USD375,880,000USD301,083,000USD357,161,000USD
    Cash And Equivalents378,564,000USD290,188,000USD222,848,000USD292,034,000USD445,084,000USD375,880,000USD301,083,000USD357,161,000USD
    Cash And Short Term Investments393,264,000USD306,160,000USD222,848,000USD292,034,000USD445,084,000USD375,880,000USD301,083,000USD357,161,000USD
    Total Current Assets1,938,338,000USD1,471,124,000USD1,407,406,000USD1,410,983,000USD1,429,118,000USD1,422,425,000USD1,306,332,000USD1,236,169,000USD
    Total Current Liabilities762,026,000USD649,360,000USD606,745,000USD581,492,000USD680,119,000USD540,027,000USD563,055,000USD582,456,000USD
    Net Debt2,332,395,000USD1,464,837,000USD1,703,524,000USD1,539,926,000USD1,521,051,000USD2,188,605,000USD1,709,232,000USD1,801,664,000USD
    Short Term Debt100,000,000USD100,000,000USD87,500,000USD87,500,000USD110,000,000USD100,500,000USD50,000,000USD86,625,000USD
    Short Long Term Debt100,000,000USD100,000,000USD87,500,000USD87,500,000USD110,000,000USD100,500,000USD50,000,000USD86,625,000USD
    Short Long Term Debt Total2,725,659,000USD1,755,025,000USD1,926,372,000USD1,831,960,000USD1,966,135,000USD2,564,485,000USD2,010,315,000USD2,158,825,000USD
    Long Term Debt2,541,449,000USD1,555,871,000USD1,727,572,000USD1,624,023,000USD1,740,102,000USD2,377,888,000USD1,858,943,000USD2,072,200,000USD
    Net Receivables345,583,000USD459,495,000USD443,467,000USD408,834,000USD383,569,000USD395,071,000USD418,673,000USD366,286,000USD
    Inventory404,395,000USD600,133,000USD626,216,000USD578,507,000USD477,643,000USD513,196,000USD476,557,000USD427,778,000USD
    Accounts Payable130,201,000USD141,031,000USD132,247,000USD126,807,000USD118,236,000USD102,520,000USD102,916,000USD106,709,000USD
    Property Plant Equipment Net590,098,000USD611,764,000USD603,434,000USD578,416,000USD573,411,000USD574,547,000USD543,879,000USD432,766,000USD
    Property Plant Equipment Gross1,060,153,000USD1,222,446,000USD1,176,599,000USD447,205,000USD443,758,000USD473,912,000USD543,879,000USD432,766,000USD
    Accumulated Other Comprehensive Income-239,468,000USD-316,669,000USD-314,405,000USD-403,522,000USD-346,959,000USD-297,298,000USD-344,392,000USD-341,085,000USD
    Common Stock Shares Outstanding44,724,000shares47,094,000shares47,304,000shares47,309,000shares47,427,000shares47,287,000shares47,090,000shares46,801,000shares
    Non Current Assets Total5,008,901,000USD5,626,790,000USD6,125,140,000USD5,517,080,000USD5,442,604,000USD5,730,134,000USD5,003,488,000USD5,041,822,000USD
    Non Current Liabilities Total3,060,445,000USD2,170,414,000USD2,484,813,000USD2,324,603,000USD2,436,855,000USD3,276,075,000USD2,767,445,000USD3,155,557,000USD
    Non Current Liabilities Other198,068,000USD104,138,000USD165,872,000USD159,863,000USD165,411,000USD322,920,000USD82,719,000USD92,914,000USD
    Non Currrent Assets Other565,817,000USD102,624,000USD98,943,000USD77,455,000USD69,104,000USD41,802,000USD52,447,000USD32,279,000USD
    Net Working Capital1,176,312,000USD821,764,000USD800,661,000USD829,491,000USD748,999,000USD882,398,000USD743,277,000USD653,713,000USD
    Unclassified Non Current Assets-565,817,000USD-102,624,000USD-98,943,000USD-77,455,000USD-69,104,000USD-142,437,000USD-52,447,000USD—
    Unclassified Current Liabilities-81,213,000USD-58,682,000USD-87,500,000USD-62,764,000USD-422,307,000USD-366,277,000USD-271,961,000USD-86,625,000USD
    Unclassified Non Current Liabilities320,928,000USD510,405,000USD591,369,000USD-39,426,000USD-49,378,000USD-236,823,000USD-420,905,000USD-693,342,000USD
    Unclassified Equity118,082,000USD382,747,000USD549,565,000USD667,161,000USD645,161,000USD604,493,000USD569,444,000USD527,513,000USD
    Short Term Investments—15,972,000USD16,883,000USD48,503,000USD21,718,000USD20,106,000USD21,575,000USD14,728,000USD
    Current Deferred Revenue——41,453,000USD—396,250,000USD283,138,000USD228,653,000USD5,943,000USD
    Unclassified Current Assets——-16,883,000USD-48,503,000USD-21,718,000USD-20,106,000USD-21,575,000USD-14,728,000USD
    Other Liab———580,143,000USD580,720,000USD812,090,000USD807,130,000USD1,075,564,000USD
    Treasury Stock———-154,889,000USD-157,266,000USD-162,590,000USD-165,720,000USD-168,545,000USD
    Net Tangible Assets———-820,927,000USD-1,038,521,000USD-1,769,255,000USD-1,422,270,000USD-2,031,653,000USD
    Deferred Long Term Liab——————439,558,000USD608,221,000USD
    Long Term Investments——————13,066,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation103,563,000USD
    Stock Based Compensation12,182,000USD
    Deferred Income Tax-16,090,000USD
    Other Non Cash Items-1,150,000USD
    Change To Account Receivables-23,639,000USD
    Change To Inventory44,252,000USD
    Change To Liabilities-6,053,000USD
    Change In Working Capital27,448,000USD
    Operating Cash Flow143,355,000USD
    Capital Expenditures-32,825,000USD
    Net Investments-9,000,000USD
    Unclassified Investing Cash Flow-57,686,000USD
    Investing Cash Flow-99,511,000USD
    Net Debt Issuance175,000,000USD
    Net Common Stock Issuance-250,000,000USD
    Common Dividends Paid-29,830,000USD
    Unclassified Financing Cash Flow-22,155,000USD
    Financing Cash Flow-126,985,000USD
    Effect Of Forex Changes On Cash-6,420,000USD
    Change In Cash-89,561,000USD
    End Cash Flow316,919,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-8,154,000USD-3,551,999USD-408,892,000USD122,580,000USD95,002,000USD-136,656,000USD111,004,000USD80,038,000USD
    Depreciation53,743,000USD-33,230,000USD77,925,000USD65,712,000USD67,331,000USD71,792,000USD68,636,000USD68,129,000USD
    Stock Based Compensation6,742,000USD2,897,000USD8,031,000USD6,941,000USD7,826,000USD7,621,000USD7,988,000USD8,610,000USD
    Other Non Cash Items17,898,000USD53,619,999USD503,150,000USD-44,297,000USD-28,645,000USD257,525,000USD-7,398,000USD3,607,000USD
    Change To Account Receivables-25,005,000USD7,999,000USD-51,858,000USD-36,570,000USD-5,104,000USD-2,658,000USD-14,056,000USD-1,689,000USD
    Change To Inventory16,473,000USD78,346,000USD56,288,000USD-21,104,000USD-29,489,000USD13,560,000USD25,497,000USD-12,055,000USD
    Change In Working Capital-10,857,000USD164,057,000USD-35,466,000USD-140,887,000USD-68,792,000USD71,777,000USD48,441,000USD-64,401,000USD
    Total Cash From Operating Activities46,662,000USD152,207,000USD107,634,000USD7,742,000USD73,094,000USD202,470,000USD230,976,000USD91,312,000USD
    Capital Expenditures-18,791,000USD-651,000USD-29,946,000USD-34,628,000USD-30,011,000USD-32,022,000USD-21,180,000USD-34,800,000USD
    Free Cash Flow46,662,000USD151,556,000USD77,688,000USD-26,886,000USD43,083,000USD170,448,000USD209,796,000USD56,512,000USD
    Investments-55,994,000USD-7,612,000USD-767,502,000USD-30,486,000USD-28,794,000USD-23,088,000USD-21,230,000USD-30,233,000USD
    Total Cashflows From Investing Activities-74,785,000USD-22,409,000USD-767,502,000USD-30,486,000USD-28,794,000USD-23,088,000USD-21,230,000USD-30,233,000USD
    Net Borrowings-25,250,000USD-26,289,000USD771,464,000USD-9,050,000USD250,875,000USD-103,125,000USD39,875,000USD—
    Total Cash From Financing Activities-44,985,000USD-61,609,000USD756,340,000USD-23,668,000USD-59,524,000USD-119,115,000USD-174,818,000USD-56,544,000USD
    Dividends Paid-15,050,000USD-15,026,000USD-15,024,000USD-15,027,000USD-15,191,000USD-15,733,000USD-15,790,000USD-16,017,000USD
    Sale Purchase Of Stock-4,627,000USD-294,727,000USD-46,000USD-1,894,000USD-300,000,000USD-203,000USD-200,000,000USD0USD
    Change In Cash-84,850,000USD9,867,000USD97,388,000USD-33,556,000USD-10,172,000USD49,885,000USD39,198,000USD1,144,000USD
    Begin Period Cash Flow414,400,000USD368,697,000USD283,922,000USD317,478,000USD327,650,000USD277,765,000USD238,567,000USD237,423,000USD
    End Period Cash Flow329,550,000USD378,564,000USD381,310,000USD283,922,000USD317,478,000USD327,650,000USD277,765,000USD238,567,000USD
    Other Cashflows From Investing Activities-53,494,000USD-23,072,000USD88,915,000USD3,140,000USD6,307,000USD27,196,000USD18,142,000USD4,567,000USD
    Other Cashflows From Financing Activities-58,000USD-10,372,000USD-2,215,000USD2,303,000USD4,792,000USD-54,000USD1,097,000USD598,000USD
    Unclassified Operating Cash Flow-12,710,000USD-31,585,000USD-37,114,000USD-2,307,000USD—-69,589,000USD—-4,671,000USD
    Unclassified Investing Cash Flow53,494,000USD8,926,000USD-58,969,000USD31,488,000USD23,704,000USD4,826,000USD3,038,000USD30,233,000USD
    Unclassified Financing Cash Flow—284,805,000USD—————-41,125,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income58,530,000USD69,675,000USD356,328,000USD363,139,000USD485,374,000USD335,324,000USD461,466,000USD200,802,000USD
    Depreciation177,738,000USD274,601,000USD242,118,000USD230,590,000USD237,362,000USD227,252,000USD214,062,000USD209,980,000USD
    Stock Based Compensation25,695,000USD31,348,000USD31,465,000USD27,224,000USD22,937,000USD20,739,000USD26,940,000USD22,438,000USD
    Other Non Cash Items286,464,000USD261,937,000USD5,545,000USD-25,840,000USD-111,360,000USD-136,514,000USD20,147,000USD54,552,000USD
    Change To Account Receivables-85,533,000USD-27,952,000USD-15,763,000USD-38,459,000USD-600,000USD44,748,000USD-59,793,000USD-23,412,000USD
    Change To Inventory84,041,000USD1,722,000USD-41,068,000USD-110,686,000USD-11,138,000USD-5,497,000USD-53,170,000USD-37,198,000USD
    Change In Working Capital-81,088,000USD-1,822,000USD-111,772,000USD-239,964,000USD127,345,000USD22,280,000USD-114,496,000USD-44,297,000USD
    Total Cash From Operating Activities340,677,000USD635,739,000USD510,638,000USD342,141,000USD651,419,000USD436,406,000USD439,525,000USD437,378,000USD
    Capital Expenditures-95,236,000USD-126,434,000USD-91,442,000USD-79,190,000USD-71,618,000USD-90,694,000USD-102,695,000USD-80,795,000USD
    Free Cash Flow245,441,000USD509,305,000USD419,196,000USD262,951,000USD579,801,000USD345,712,000USD336,830,000USD356,583,000USD
    Investments-5,000,000USD-99,358,000USD-258,431,000USD-257,941,000USD-18,418,000USD19,341,000USD18,331,000USD1,548,000USD
    Total Cashflows From Investing Activities-849,191,000USD-99,358,000USD-621,228,000USD-257,941,000USD156,737,000USD-837,783,000USD-73,481,000USD-196,394,000USD
    Net Borrowings987,000,000USD-161,500,000USD101,250,000USD-145,450,000USD-634,500,000USD566,560,000USD275,000,000USD35,000,000USD
    Total Cash From Financing Activities611,539,000USD-421,925,000USD38,540,000USD-217,506,000USD-715,822,000USD455,163,000USD-418,836,000USD-206,433,000USD
    Dividends Paid-60,268,000USD-63,541,000USD-63,896,000USD-63,789,000USD-63,648,000USD-63,221,000USD-62,828,000USD-62,165,000USD
    Sale Purchase Of Stock-300,000,000USD-200,000,000USD5,190,000USD-4,308,000USD412,451,000USD18,994,000USD21,206,000USD22,655,000USD
    Change In Cash73,676,000USD104,802,000USD-69,186,000USD-153,050,000USD69,204,000USD74,797,000USD-56,078,000USD23,603,000USD
    Begin Period Cash Flow304,888,000USD222,848,000USD292,034,000USD445,084,000USD375,880,000USD301,083,000USD357,161,000USD333,558,000USD
    End Period Cash Flow378,564,000USD327,650,000USD222,848,000USD292,034,000USD445,084,000USD375,880,000USD301,083,000USD357,161,000USD
    Other Cashflows From Investing Activities76,190,000USD27,196,000USD63,134,000USD-178,751,000USD228,355,000USD-766,430,000USD14,345,000USD1,548,000USD
    Other Cashflows From Financing Activities-10,232,000USD3,116,000USD1,186,000USD730,783,000USD-41,222,000USD1,457,191,000USD172,492,000USD-50,768,000USD
    Unclassified Operating Cash Flow-126,662,000USD—-13,046,000USD-13,008,000USD-110,239,000USD-32,675,000USD-168,594,000USD-6,097,000USD
    Unclassified Investing Cash Flow-825,145,000USD99,238,000USD-334,489,000USD257,941,000USD18,418,000USD—-3,462,000USD-118,695,000USD
    Issuance Of Capital Stock——0USD0USD11,097,000USD0USD——
    Unclassified Financing Cash Flow——-5,190,000USD-734,742,000USD-388,903,000USD-1,524,361,000USD-824,706,000USD-151,155,000USD
    Change To Liabilities———-104,239,000USD94,020,000USD-12,648,000USD29,490,000USD26,664,000USD
    Cash And Cash Equivalents Changes———-134,110,000USD93,054,000USD54,523,000USD-55,249,000USD23,603,000USD
    Exchange Rate Changes———————-10,948,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductInterventional211,874,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSurgical112,121,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductVascular Access246,337,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentAmericas348,838,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentAsia75,963,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentEMEA145,531,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductInterventional204,656,000USD0000096943-26-000050
    Q1 2026Quarterly · 2026-03-31ProductSurgical106,794,000USD0000096943-26-000050
    Q1 2026Quarterly · 2026-03-31ProductVascular Access236,812,000USD0000096943-26-000050
    Q1 2026Quarterly · 2026-03-31GeographyAmericas332,653,000USD0000096943-26-000050
    Q1 2026Quarterly · 2026-03-31GeographyEMEA146,678,000USD0000096943-26-000050
    Q1 2026Quarterly · 2026-03-31GeographyOther68,931,000USD0000096943-26-000050
    FY 2025Yearly · 2025-12-31ProductInterventional647,792,000USD0000096943-26-000019
    FY 2025Yearly · 2025-12-31ProductOther9,035,000USD0000096943-26-000019
    FY 2025Yearly · 2025-12-31ProductSurgical418,155,000USD0000096943-26-000019
    FY 2025Yearly · 2025-12-31ProductVascular Access917,731,000USD0000096943-26-000019
    Q3 2025Quarterly · 2025-09-30ProductAnesthesia101,449,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30ProductInterventional266,412,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30ProductInterventional Urology71,770,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30ProductOem80,412,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30ProductOther79,078,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30ProductSurgical122,879,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30ProductVascular Access191,021,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30GeographyAmericas555,900,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30GeographyEMEA234,247,000USD0000096943-25-000138
    Q3 2025Quarterly · 2025-09-30GeographyOther122,874,000USD0000096943-25-000138
    Q2 2025Quarterly · 2025-06-30ProductAnesthesia96,386,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30ProductInterventional170,019,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30ProductInterventional Urology76,388,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30ProductOem78,675,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30ProductOther59,848,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30ProductSurgical114,042,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30ProductVascular Access185,531,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30GeographyAmericas525,637,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30GeographyEMEA166,227,000USD0000096943-25-000115
    Q2 2025Quarterly · 2025-06-30GeographyOther89,025,000USD0000096943-25-000115
    Q1 2025Quarterly · 2025-03-31ProductInterventional100,151,000USD0000096943-26-000050
    Q1 2025Quarterly · 2025-03-31ProductSurgical94,976,000USD0000096943-26-000050
    Q1 2025Quarterly · 2025-03-31ProductVascular Access219,131,000USD0000096943-26-000050
    Q1 2025Quarterly · 2025-03-31GeographyAmericas289,726,000USD0000096943-26-000050
    Q1 2025Quarterly · 2025-03-31GeographyEMEA82,639,000USD0000096943-26-000050
    Q1 2025Quarterly · 2025-03-31GeographyOther41,893,000USD0000096943-26-000050
    Q4 2024Quarterly · 2024-12-31ProductAnesthesia95,288,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductInterventional160,370,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductInterventional Urology84,851,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOem85,431,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther58,241,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSurgical121,908,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductVascular Access189,320,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductInterventional397,340,000USD0000096943-26-000019
    FY 2024Yearly · 2024-12-31ProductOther-6,175,000USD0000096943-26-000019
    FY 2024Yearly · 2024-12-31ProductSurgical404,869,000USD0000096943-26-000019
    FY 2024Yearly · 2024-12-31ProductVascular Access903,512,000USD0000096943-26-000019
    Q3 2024Quarterly · 2024-09-30ProductAnesthesia101,154,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30ProductInterventional149,865,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30ProductInterventional Urology83,395,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30ProductOem82,558,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30ProductOther54,761,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30ProductSurgical111,746,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30ProductVascular Access180,896,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30GeographyAmericas515,888,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30GeographyEMEA150,224,000USD0000096943-25-000138
    Q3 2024Quarterly · 2024-09-30GeographyOther98,263,000USD0000096943-25-000138
    Q2 2024Quarterly · 2024-06-30ProductAnesthesia102,491,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30ProductInterventional141,157,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30ProductInterventional Urology83,104,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30ProductOem88,825,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30ProductOther41,705,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30ProductSurgical111,304,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30ProductVascular Access181,105,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30GeographyAmericas515,632,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30GeographyEMEA147,064,000USD0000096943-25-000115
    Q2 2024Quarterly · 2024-06-30GeographyOther86,995,000USD0000096943-25-000115
    Q1 2024Quarterly · 2024-03-31GeographyAmericas493,983,000USD0000096943-25-000077
    Q1 2024Quarterly · 2024-03-31GeographyEMEA159,656,000USD0000096943-25-000077
    Q1 2024Quarterly · 2024-03-31GeographyOther84,210,000USD0000096943-25-000077
    FY 2023Yearly · 2023-12-31ProductInterventional407,251,000USD0000096943-26-000019
    FY 2023Yearly · 2023-12-31ProductOther75,751,000USD0000096943-26-000019
    FY 2023Yearly · 2023-12-31ProductSurgical388,325,000USD0000096943-26-000019
    FY 2023Yearly · 2023-12-31ProductVascular Access841,114,000USD0000096943-26-000019
    Q3 2023Quarterly · 2023-09-30GeographyAmericas428,206,000USD0000096943-24-000148
    Q3 2023Quarterly · 2023-09-30GeographyEMEA142,723,000USD0000096943-24-000148
    Q3 2023Quarterly · 2023-09-30GeographyOther175,460,000USD0000096943-24-000148
    FY 2022Yearly · 2022-12-31ProductAnesthesia388,890,000USD0000096943-25-000031
    FY 2022Yearly · 2022-12-31ProductInterventional445,018,000USD0000096943-25-000031
    FY 2022Yearly · 2022-12-31ProductInterventional Urology322,832,000USD0000096943-25-000031
    FY 2022Yearly · 2022-12-31ProductOem272,624,000USD0000096943-25-000031
    FY 2022Yearly · 2022-12-31ProductOther285,148,000USD0000096943-25-000031
    FY 2022Yearly · 2022-12-31ProductSurgical392,917,000USD0000096943-25-000031
    FY 2022Yearly · 2022-12-31ProductVascular Access683,612,000USD0000096943-25-000031
    FY 2021Yearly · 2021-12-31ProductAnesthesia380,140,000USD0000096943-24-000036
    FY 2021Yearly · 2021-12-31ProductInterventional427,500,000USD0000096943-24-000036
    FY 2021Yearly · 2021-12-31ProductInterventional Urology341,661,000USD0000096943-24-000036
    FY 2021Yearly · 2021-12-31ProductOem245,681,000USD0000096943-24-000036
    FY 2021Yearly · 2021-12-31ProductOther336,585,000USD0000096943-24-000036
    FY 2021Yearly · 2021-12-31ProductSurgical377,756,000USD0000096943-24-000036
    FY 2021Yearly · 2021-12-31ProductVascular Access700,240,000USD0000096943-24-000036
    FY 2020Yearly · 2020-12-31ProductAnesthesia302,293,000USD0000096943-23-000024
    FY 2020Yearly · 2020-12-31ProductInterventional382,435,000USD0000096943-23-000024
    FY 2020Yearly · 2020-12-31ProductInterventional Urology290,022,000USD0000096943-23-000024

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.